THE EFFECT OF ANTI-IGE THERAPY IN KNEE OSTEOARTHRITIS: A PILOT OBSERVATIONAL STUDY

A. AQUILI, L. FARINELLI, C. BOTTEGONI, L. ANTONICELLI, A. GIGANTE

Article ID: 6524
Vol 31, Issue 4S1, 2017
DOI: https://doi.org/10.54517/jbrha6524
Received: 8 January 2018; Accepted: 8 January 2018; Available online: 8 January 2018; Issue release: 8 January 2018

Abstract

Osteoarthritis is a whole-joint disease and its pathogenesis remains poorly understood. Recentevidence proposed the importance of the innate immune system as trigger of synovium inflammationfollowing the degeneration of cartilage. Moreover, synovial mast cells (MCs) might be correlated withpain and disability reported by patients. Anti IgE therapy represents a new class of MCs stabilizingagent, licensed for people with asthma and chronic urticaria. Therefore, we studied if the stabilizingeffect of anti IgE would improve the pain and disability in patients affected by knee osteoarthritis andatopic disease. This pilot study provides the first evidence that anti IgE treatment induces a short-termclinical improvement supporting the role of MCs in osteoarthritis.


Keywords

osteoarthritis;synovial mast cells;Omalizumab


References

Supporting Agencies



Copyright (c) 2017 A. AQUILI, L. FARINELLI, C. BOTTEGONI, L. ANTONICELLI, A. GIGANTE




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).